- Home
- ACN vs BSX Comparison
ACN vs BSX Comparison
Compare ACN & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACN
- BSX
- Stock Information
- Founded
- ACN 1989
- BSX 1979
- Country
- ACN Ireland
- BSX United States
- Employees
- ACN N/A
- BSX N/A
- Industry
- ACN Business Services
- BSX Medical/Dental Instruments
- Sector
- ACN Consumer Discretionary
- BSX Health Care
- Exchange
- ACN Nasdaq
- BSX Nasdaq
- Market Cap
- ACN 161.9B
- BSX 157.6B
- IPO Year
- ACN N/A
- BSX 1992
- Fundamental
- Price
- ACN $241.70
- BSX $98.31
- Analyst Decision
- ACN Buy
- BSX Strong Buy
- Analyst Count
- ACN 22
- BSX 22
- Target Price
- ACN $332.23
- BSX $118.91
- AVG Volume (30 Days)
- ACN 3.9M
- BSX 7.3M
- Earning Date
- ACN 09-25-2025
- BSX 10-22-2025
- Dividend Yield
- ACN 2.50%
- BSX N/A
- EPS Growth
- ACN 15.02
- BSX 36.90
- EPS
- ACN 12.56
- BSX 1.68
- Revenue
- ACN $68,482,535,999.00
- BSX $18,494,000,000.00
- Revenue This Year
- ACN $8.05
- BSX $19.75
- Revenue Next Year
- ACN $5.40
- BSX $10.98
- P/E Ratio
- ACN $18.83
- BSX $58.92
- Revenue Growth
- ACN 6.21
- BSX 21.44
- 52 Week Low
- ACN $235.85
- BSX $80.64
- 52 Week High
- ACN $398.35
- BSX $109.50
- Technical
- Relative Strength Index (RSI)
- ACN 37.55
- BSX 27.85
- Support Level
- ACN $235.83
- BSX $104.24
- Resistance Level
- ACN $245.25
- BSX $109.50
- Average True Range (ATR)
- ACN 6.18
- BSX 2.11
- MACD
- ACN -0.86
- BSX -1.02
- Stochastic Oscillator
- ACN 23.52
- BSX 5.82
About ACN Accenture plc (Ireland)
Accenture is a leading IT services firm that provides consulting, system integration, and business process outsourcing to enterprises around the world. Customers of Accenture come from a variety of sectors, including communications, media and technology, financial services, health and public services, consumer products, and resources. Accenture is the world's largest professional services company by headcount with around 800,000 employees in over 120 countries.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.